Definition and Overview
Long COVID dysautonomia refers to autonomic nervous system dysfunction persisting more than 12 weeks after acute SARS-CoV-2 infection. It is one of the most debilitating manifestations of post-COVID condition, affecting approximately 30-50% of long COVID patients [1].
The most common presentation is postural orthostatic tachycardia syndrome (POTS), characterized by an excessive heart rate increase of 30 or more bpm within 10 minutes of standing. Other manifestations include orthostatic intolerance, exercise intolerance, fatigue, and gastrointestinal dysmotility.
Pathophysiology
Proposed mechanisms include autoimmune attack on autonomic ganglia and adrenergic/muscarinic receptors, direct viral neurotropism affecting autonomic centers, endothelial damage and microvascular dysfunction, and mast cell activation [2].
Autoantibodies against G-protein coupled receptors (anti-alpha1 adrenergic, anti-beta2 adrenergic, anti-muscarinic M2) have been detected in post-COVID POTS patients. Small fiber neuropathy affecting autonomic C-fibers has been documented on skin biopsy [3].
Symptoms
- Orthostatic symptoms: dizziness, lightheadedness, presyncope upon standing
- POTS: excessive tachycardia with standing, palpitations
- Exercise intolerance: disproportionate fatigue and symptoms with minimal exertion
- Gastrointestinal: nausea, bloating, early satiety, gastroparesis
- Sudomotor: abnormal sweating patterns
- Cognitive: brain fog, difficulty concentrating
Diagnosis
Active standing test (10-minute stand test with continuous heart rate/BP monitoring) is the primary screening tool. Tilt table testing provides definitive POTS diagnosis. HRV analysis reveals reduced overall variability and impaired baroreflex sensitivity [1].
QSART evaluates sudomotor function. Skin biopsy quantifies intraepidermal nerve fiber density for small fiber neuropathy diagnosis. Autoantibody panels are being developed.
Treatment
Non-pharmacological measures are the foundation: increased fluid intake (2-3L/day), increased salt intake (6-10g/day), compression garments (waist-high, 30-40 mmHg), and counter-pressure maneuvers [4].
Graduated exercise program starting with recumbent exercises (swimming, recumbent cycling) and progressively transitioning to upright exercises over 3-6 months. The Dallas POTS exercise protocol is commonly used.
Pharmacotherapy: fludrocortisone (volume expansion), midodrine (vasoconstriction), ivabradine (heart rate reduction), propranolol (low-dose for hyperadrenergic POTS). For autoimmune-mediated cases, IVIG has shown benefit in case series [5].